Integration of Stepped Care for Perinatal Mood and Anxiety Disorders Among Women Attending MCH Clinics
Key facts
- Who runs it
- Kenyatta National Hospital
- Where
- Kenya2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,970 people, planned
- Started
- 17 Feb 2025
- Expected to end
- Mar 2028
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Integrated Perinatal Mental health program (systematic screening for PMAD, PM+ and tele-psychiatry)
- Record updated
- 10 December 2025
Who can take part
- Age
- 14 years and older
- Sex
- Women only
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Pregnant and ≥28 weeks gestation
- Attending ANC care at the facility
- ≥14 years old
- Screen positive for PMAD symptoms (PHQ-2≥3 and/or GAD-2≥3)
- Willing to return to the MCH and PMTCT clinic for study visits
Who cannot take part
- Less than 28 weeks gestation
- Any woman at high risk of self-harm based on a study self-harm assessment protocol,
- Has cognitive impairments or psychotic symptoms
This trial is currently available in Kenya.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Perinatal mood and anxiety disorders (PMAD), defined as depression and anxiety during pregnancy or up to 1 year postpartum, account for substantial morbidity and mortality among birthing people globally especially in low- and middle-income countries. Several evidence-based interventions are recommended for identification and management of PMAD by non-specialist providers in resource-limited settings. This cluster-randomized trial seeks to evaluate the effect of a stepped-care intervention for screening and treatment of PMAD among perinatal women, on clinical and implementation outcomes.
The 2 groups in the trial
- Control arm: Enhanced Standard of careNo study treatment, for comparison
Control facilities will provide enhanced standard of care. The enhanced standard of care will include two enhancements: 1. HIV Testing Services (HTS) providers and lay workers will conduct screening for perinatal mood and anxiety disorders (PMAD) using the PHQ-2 and GAD-2. 2. The study team will provide a PMAD referral information sheet to all control facilities describing inpatient and outpatient psychiatry services at the nearby referral hospitals
- Intervention arm: Integrated Perinatal Mental Health Program (IPMH)Treatment being tested
Intervention facilities will receive the Integrated Perinatal Mental Health Program (IPMH). This includes: 1. Systematic screening for PMAD symptoms using PHQ-2 and GAD-2. Positive screeners (PHQ-2≥3 and/or GAD-2≥3) will then be referred to nurses to administer additional screening by PHQ-9 and GAD-7 2. Non-specialist delivery of PM+ for participants with likely depression (PHQ-9≥10) or anxiety (GAD-7≥10) delivered weekly 3. In-facility tele-linkage to mental health specialist for participants with severe depressive symptoms (PHQ-9≥15), those who endorse suicidality, or non-responders to Problem Management+
Treatment: Integrated Perinatal Mental health program (systematic screening for PMAD, PM+ and tele-psychiatry)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Integration of stepped care for perinatal mood and anxiety disorders among women attending maternal and child health clinics in Kenya: Protocol for a cluster randomized controlled trial.PloS one, 2026
- Integration of stepped care for perinatal mood and anxiety disorders among women attending maternal and child health clinics in Kenya: Protocol for a cluster randomized controlled trial.medRxiv : the preprint server for health sciences, 2026
- Record updated
- 10 December 2025